Did you know less than 10% of new compounds reach the market? Advanced biostatistics services and efficient clinical development strategies is crucial to shorten trial timelines, reduce risk and improve the quality of submissions is vital. IDDI’s Biostatisical state-of-the-art methods play a key role in every step of the drug development process for trial success. Learn more about what we can do for your next project
http://ow.ly/EU4S50Am4Us

See all Member News